科室及职务
诊疗专长
| 姓名 | 安萍 |
| 出生年月 | 1975年3月 |
| 单位 | 武汉大学人民医院消化内Ⅲ科（肠病及肠菌移植中心） |
| 所属学科 | 临床医学-内科学 |
| 职务、职称及头衔 | 科主任，主任医师，副教授，博士生导师 |
| anping_05@163.com | |
| 联系方式 | 18627068700 |
| 研究方向 |
1.炎症性肠病的临床与基础研究 2.肠道微生态机制及肠菌移植应用 3.肝纤维化、肠纤维化机制研究 4.消化道早癌发生发展的内镜及机制研究 |
| 个人简介 | |
| 安萍，主任医师，副教授，博士生导师，哈佛大学医学院及首尔国立大学博士后，加州大学UCLA及芝加哥大学访问学者，现任武汉大学人民医院消化内Ⅲ科（肠病及肠菌移植中心）主任。精于消化道早癌及癌前病变的多种内镜技术精准筛查与内镜下治疗；精于炎症性肠病等疑难、重症肠道疾病的临床诊疗，危重急症肠道疾病抢救经验丰富；对肠道微生态及肠菌移植有深入研究诊疗经验丰富；精于各种胃镜结肠镜、超声内镜及小肠镜的诊疗操作；在肝纤维化及肝硬化的基础研究和临床诊治上有较深造诣。主持2项国家自然科学基金、6项省市级科研项目、11项国际多中心临床研究，参编2部专著。在Nature Communication、Lancet Gastroenterology and Hepatology、Hepatology等权威期刊发表SCI论文40余篇。培养硕士、博士研究生10余名。 | |
| 学术任职与荣誉 | |
| 中华医学会消化病分会炎症性肠病学组心理协作组委员、中华医学会消化病学分会营养支持与治疗协作组组员、中华医学会消化内镜分会早癌协作组委员、中国人体健康科技促进会肠道微生态及肠菌移植专业委员会委员、中国中西医综合学会消化内镜专委会IBD专家委会委员、湖北省病理生理学会消化专业委员会炎症性肠病学组副组长、湖北省炎症性肠病联盟副理事长、湖北省肝胆疾病学会理事会理事、湖北省消化内镜学会肠病学组副组长、湖北省微循环学会黏膜学组副组长、湖北省临床肿瘤学会食管癌专家委员会委员等。 | |
| 教育履历 | |
|
1993.09-1998.06武汉大学医学院临床医疗系获学士学位 2001.09-2004.06武汉大学第一临床学院内科学硕士研究生获硕士学位 2004.09-2007.06武汉大学第一临床学院内科学博士研究生获博士学位 2010.03-2011.02首尔国立大学博士后 2015.08-2018.08哈佛医学院博士后 |
|
| 工作履历 | |
|
1998.07-2000.10武汉市三医院消化内科 住院医师 2011.07-2013.11武汉大学人民医院消化内科主治医师 2013.11-2020.06武汉大学人民医院消化内科副主任医师 2014.11-至今 武汉大学人民医院消化内科副教授，硕士生导师 2020.06-至今 武汉大学人民医院消化内科主任医师 2023.10-至今 武汉大学人民医院消化内Ⅲ科（肠病及肠菌移植中心）科主任 2024.06-至今 武汉大学人民医院消化内科博士生导师 |
|
| 成果获奖 | |
|
1.全国消化道早癌内镜菁英大赛一等奖 2.探索以模拟教学、PBL、CBL教学和课堂授课等方法相结合的教学模式，获全国高校混合式教学设计创新大赛设计之星奖 3.《肠之谜-肠道疾病常规临床诊断思维的破局者》获全国虚拟仿真实验教学创新大赛优秀奖 4.武汉大学青年教师讲课比赛一等奖 5.中华医学会教育学分会医学院校青年教师教学基本功比赛二等奖 |
|
| 代表性论著 | |
|
1. An P, Wei LL, Zhao S, Sverdlov DY, Vaid KA,
Miyamoto M, Kuramitsu K, Lai M, Popov YV. Hepatocyte mitochondria-derived
danger signals directly activate hepatic stellate cells and drive progression
of liver fibrosis. Nat Commun. 2020;11(1):2362.（一区, IF=14.7） 2. An P, Ji M, Ren H, et al. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China. Lancet Gastroenterol Hepatol. 2020; 5(6): 525-527.（一区, IF=30.9） 3. Wang W, Yin A, Wang J, Li J, Cheng J, Kang J, Xu Y, Lu Y, Yang Y, Su J, Zhou Q, Liu Y, Tang Z, Ren H, Li W, Dong W, Yu B, An P. Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study. Clin Nutr. 2024 Jun;43(6):1291-1298.（一区, IF=6.6） 4. An P, Yang D, Wang J, Wu L, Zhou J, Zeng Z, Huang X, Xiao Y, Hu S, Chen Y, Yao F, Guo M, Wu Q, Yang Y, Yu H. A deep learning method for delineating early gastric cancer resection margin under chromoendoscopy and white light endoscopy. Gastric Cancer. 2020. 23(5):884-892.（一区, IF=6.0） 5. An P, Huang X, Wan X, et al. ERCP during the pandemic of COVID-19 in Wuhan, China [published online ahead of print, 2020 Apr 16]. Gastrointest Endosc. 2020;92(2):448-454.（一区, IF=6.7） 6. Kang J, Su J, Wang J, Ren H, Yin A, Li J, Zhou Q, Wang Y, Zhu P, Zou L, Wang W, Tang Z, Dong W, Ding Y, An P. An education-based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study). United European Gastroenterol J. 2023 Dec;11(10):960-972.（二区, IF=5.8） 7. An P, Wei G, Huang P, Li W, Qi X, Lin Y, Vaid KA, Wang J, Zhang S, Li Y, Or YS, Jiang LJ, Popov YV. A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction. Liver Int. 2020;40(7):1655-1669.（二区, IF=6.0） 8. Jing W, Zhi Z, Shiying Z, Jian K, Xiaoda J, Xu H, Jiao L, Juan S, Zi L, Peng Z, Jingping Y, Ping An. Targeted labeling with tissue marking dyes guided by magnifying endoscopy of endoscopic submucosal dissection specimen improves the accuracy of endoscopic and histopathological diagnosis of early gastric cancer: a before–after study. Surgical Endoscopy. 2023, Apr;37(4):2897-2907（二区, IF=2.4） 9. Liping Zou, Juan Su, Jiao Li, Jing Wang, Jian Kang, Anning Yin, Haixia Ren, Xiaoda Jiang, Yijuan Ding, Ping An. Application of Bilingual Simulated Patients in the Medical History Collection for International Medical Students in China. BMC Med Educ. 2023; 23: 525.（二区, IF=2.7） 10. Zeng S, Liu C, Zhang J, An P, Liu Z, Jiang C, Shi J, Wu K, Dong W. Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study. Front Psychiatry. 2023 Mar 9;14:1130396.（二区, IF=3.2） 11. Ren H, Kang J, Wang J, Su J, Zou L, Yin A, Li J, Zhou Q, Wang W, Tang Z, Zhang J, Lu Y, Yang Y, Qiu C, Ding Y, Dong W, An P. Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease. Inflamm Bowel Dis. 2023 Aug 24:izad184.（三区, IF=4.5） 12. Liu C, Zhang J, Chen M, An P, Xiang J, Yu R, Zeng S, Wei S, Deng B, Liu Z, Jiang C, Shi J, Wu K, Dong W. Gender Differences in Psychological Symptoms and Quality of Life in Patients with Inflammatory Bowel Disease in China: A Multicenter Study. J Clin Med. 2023 Feb 23;12(5):1791.（三区, IF=3.0） 13. An P, Chen H, Ren H, Su J, Ji M, Kang J, Jiang X, Yang Y, Li J, Lv X, Yin A, Chen D, Chen M, Zhou Z, Dong W, Ding Y, Yu H. Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China. Dig Dis Sci. 2020 Nov 12:1–10.（三区, IF=2.5） 14. Chen W, Chen Y, Su J, Kang J, Ding Y, Ai W, Zhang J, Luo H, An P. CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells. Dig Dis Sci. 2022 Jan;67(1):134-145.（三区, IF=2.5） |
| Name | PING AN |
| Date of birth | March, 1975 |
| Department | Department of Gastroenterology III (Center for Enteropathy and Enterobacteria Transplantation), Renmin Hospital of Wuhan University |
| Title | Director, Chief Physician, Associate Professor, Doctoral Tutor |
| anping_05@163.com | |
| TEL | 18627068700 |
| Research Direction | |
|
1. Clinical and basic research on inflammatory
bowel disease; 2. Intestinal microecological mechanism and application of intestinal bacterial transplantation; 3. Research on the mechanism of liver fibrosis and intestinal fibrosis; 4. Endoscopic and mechanistic studies on the development of early gastrointestinal tract cancer. |
|
| Personal Profile | |
| Ping An, Director, Chief Physician, Associate Professor, Doctoral Tutor, Postdoctoral Fellow at Harvard Medical School and Seoul National University, Visiting Scholar at UCLA and University of Chicago, is currently the Director of Gastroenterology Department III (Enteropathy and Intestinal Bacteria Transplantation Center) at Renmin Hospital of Wuhan University. She is specialized in the precision screening and endoscopic treatment of early cancer and precancerous lesions in the digestive tract; she is specialized in the clinical diagnosis and treatment of inflammatory bowel disease and other difficult and serious intestinal diseases, and has rich experience in the rescue of critical and emergency intestinal diseases; she has in-depth research on intestinal microecology and intestinal bacterial transplantation; she is specialized in the diagnostic and treatment of various kinds of gastroenteroscopes and colons, ultrasonoscopes, and small boweloscopes; she has profound attainments in the basic research and clinical diagnosis and treatment of cirrhosis of the liver. She has deep attainments in basic research and clinical diagnosis and treatment of liver cirrhosis. She has presided over 2 National Natural Science Foundation of China, 6 provincial and municipal scientific research projects, 11 international multi-center clinical studies, and participated in the editing of 2 monographs. She has published more than 40 SCI papers in prestigious journals such as Nature Communication, Lancet Gastroenterology and Hepatology, and Hepatology. She has trained more than 10 master and doctoral students up to now. | |
| Selected Publications | |
|
1. An P, Wei LL, Zhao S, Sverdlov DY, Vaid KA,
Miyamoto M, Kuramitsu K, Lai M, Popov YV. Hepatocyte mitochondria-derived
danger signals directly activate hepatic stellate cells and drive progression
of liver fibrosis. Nat Commun. 2020;11(1):2362.（一区, IF=14.7） 2. An P, Ji M, Ren H, et al. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China. Lancet Gastroenterol Hepatol. 2020; 5(6): 525-527.（一区, IF=30.9） 3. Wang W, Yin A, Wang J, Li J, Cheng J, Kang J, Xu Y, Lu Y, Yang Y, Su J, Zhou Q, Liu Y, Tang Z, Ren H, Li W, Dong W, Yu B, An P. Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study. Clin Nutr. 2024 Jun;43(6):1291-1298.（一区, IF=6.6） 4. An P, Yang D, Wang J, Wu L, Zhou J, Zeng Z, Huang X, Xiao Y, Hu S, Chen Y, Yao F, Guo M, Wu Q, Yang Y, Yu H. A deep learning method for delineating early gastric cancer resection margin under chromoendoscopy and white light endoscopy. Gastric Cancer. 2020. 23(5):884-892.（一区, IF=6.0） 5. An P, Huang X, Wan X, et al. ERCP during the pandemic of COVID-19 in Wuhan, China [published online ahead of print, 2020 Apr 16]. Gastrointest Endosc. 2020;92(2):448-454.（一区, IF=6.7） 6. Kang J, Su J, Wang J, Ren H, Yin A, Li J, Zhou Q, Wang Y, Zhu P, Zou L, Wang W, Tang Z, Dong W, Ding Y, An P. An education-based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study). United European Gastroenterol J. 2023 Dec;11(10):960-972.（二区, IF=5.8） 7. An P, Wei G, Huang P, Li W, Qi X, Lin Y, Vaid KA, Wang J, Zhang S, Li Y, Or YS, Jiang LJ, Popov YV. A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction. Liver Int. 2020;40(7):1655-1669.（二区, IF=6.0） 8. Jing W, Zhi Z, Shiying Z, Jian K, Xiaoda J, Xu H, Jiao L, Juan S, Zi L, Peng Z, Jingping Y, Ping An. Targeted labeling with tissue marking dyes guided by magnifying endoscopy of endoscopic submucosal dissection specimen improves the accuracy of endoscopic and histopathological diagnosis of early gastric cancer: a before–after study. Surgical Endoscopy. 2023, Apr;37(4):2897-2907（二区, IF=2.4） 9. Liping Zou, Juan Su, Jiao Li, Jing Wang, Jian Kang, Anning Yin, Haixia Ren, Xiaoda Jiang, Yijuan Ding, Ping An. Application of Bilingual Simulated Patients in the Medical History Collection for International Medical Students in China. BMC Med Educ. 2023; 23: 525.（二区, IF=2.7） 10. Zeng S, Liu C, Zhang J, An P, Liu Z, Jiang C, Shi J, Wu K, Dong W. Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study. Front Psychiatry. 2023 Mar 9;14:1130396.（二区, IF=3.2） 11. Ren H, Kang J, Wang J, Su J, Zou L, Yin A, Li J, Zhou Q, Wang W, Tang Z, Zhang J, Lu Y, Yang Y, Qiu C, Ding Y, Dong W, An P. Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease. Inflamm Bowel Dis. 2023 Aug 24:izad184.（三区, IF=4.5） 12. Liu C, Zhang J, Chen M, An P, Xiang J, Yu R, Zeng S, Wei S, Deng B, Liu Z, Jiang C, Shi J, Wu K, Dong W. Gender Differences in Psychological Symptoms and Quality of Life in Patients with Inflammatory Bowel Disease in China: A Multicenter Study. J Clin Med. 2023 Feb 23;12(5):1791.（三区, IF=3.0） 13. An P, Chen H, Ren H, Su J, Ji M, Kang J, Jiang X, Yang Y, Li J, Lv X, Yin A, Chen D, Chen M, Zhou Z, Dong W, Ding Y, Yu H. Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China. Dig Dis Sci. 2020 Nov 12:1–10.（三区, IF=2.5） 14. Chen W, Chen Y, Su J, Kang J, Ding Y, Ai W, Zhang J, Luo H, An P. CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells. Dig Dis Sci. 2022 Jan;67(1):134-145.（三区, IF=2.5） |
学术任职与荣誉
科研成果
| 出诊医生 | 星期一 | 星期二 | 星期三 | 星期四 | 星期五 | 星期六 | 星期日 | |||||||
| 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | |
| 安萍 | ||||||||||||||
预约方式
武汉大学人民医院
湖北省人民医院